Pressure BioSciences (PBIO) Stock Price, News & Analysis

Company Overview

Pressure BioSciences, Inc., headquartered in South Easton, Massachusetts, develops and markets novel pressure-based instruments and consumables for sample preparation in the life sciences, biotechnology and pharmaceutical industries. The company’s core innovation, Pressure Cycling Technology (PCT), uses alternating cycles of high hydrostatic pressure to facilitate efficient and reproducible cell disruption, protein extraction and subcellular fractionation. Its flagship Barocycler® instrument has been adopted by researchers working in proteomics, biomarker discovery, vaccine development and pathogen inactivation workflows.

In addition to its instrument platform, Pressure BioSciences offers a range of proprietary consumables—including pressure-resistant processing tubes and optimized reagent kits—designed to support diverse sample types such as tissue, microbes and blood derivatives. The company also markets an Ultra Shear Technology (UST) system for high-pressure homogenization, targeting applications in food science, nutraceutical development and personal care product formulation.

Pressure BioSciences serves a global customer base through direct sales and distribution partners in North America, Europe and Asia. Its clients include academic and government research institutions, contract research organizations and biotechnology and pharmaceutical companies. Although it operates as a small-cap public company on the OTC markets, the firm has established collaborative relationships with leading research centers and regularly showcases its sample-preparation solutions at scientific conferences and trade exhibitions.

Key Stats

• Today's Range: $0.0012 to $0.0012
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.20
• Volume: 100 shs
• Average Volume: 7,996 shs
• Market Capitalization: $51.56 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PBIO Stock Analysis - Frequently Asked Questions

How have PBIO shares performed this year?

Pressure BioSciences' stock was trading at $0.0005 on January 1st, 2026. Since then, PBIO stock has increased by 140.0% and is now trading at $0.0012.

How were Pressure BioSciences' earnings last quarter?

Pressure BioSciences Inc. (OTCMKTS:PBIO) posted its quarterly earnings results on Friday, February, 7th. The company reported ($0.15) earnings per share for the quarter.

How do I buy shares of Pressure BioSciences?

Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Pressure BioSciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pressure BioSciences investors own include Hydrofarm Holdings Group (HYFM), Advanced Micro Devices (AMD), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP) and Novavax (NVAX).

Company Calendar

• Last Earnings: 2/07/2025
• Today: 5/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:PBIO
• CIK: 830656
• Web: www.pressurebiosciences.com
• Phone: 508-230-1828
• Fax: 508-230-1829
• Employees: 10
• Year Founded: 2004

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.98 million
• Price / Sales: 0.03
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 42,970,000
• Free Float: 38,327,000
• Market Cap: $51.56 thousand
• Optionable: Not Optionable
• Beta: 6.15